Importance The combination of prostate-specific antigen (PSA) testing with magnetic
resonance imaging (MRI) for prostate cancer detection has rarely been evaluated in a …

Background High rates of overdiagnosis are a critical barrier to organized prostate cancer
screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential …

Background Magnetic resonance imaging (MRI) and targeted biopsies (TB) have shown
potential to more accurately detect significant prostate cancer compared with prostate …

Objective This study aimed to assess the cost-effectiveness of magnetic resonance imaging
(MRI) with combinations of targeted biopsy (TBx) and systematic biopsy (SBx) for early …

Background Stockholm3 is a risk model that combines the prostate-specific antigen (PSA)
test, other plasma protein biomarkers, single nucleotide polymorphisms, and clinical …

Objectives Our objective was to compare prostate cancer detection rates between patients
undergoing serum prostate-specific antigen (PSA) vs magnetic resonance imaging (MRI) for …

In the past decade rigorous debate has taken place about population-based screening for
prostate cancer. Although screening by serum PSA levels can reduce prostate cancer …

Importance If magnetic resonance imaging (MRI) mitigates overdiagnosis of prostate cancer
while improving the detection of clinically significant cases, including MRI in a screening …

Importance Magnetic resonance imaging (MRI) has been proposed to enhance the benefit-
to-harm ratio of prostate cancer screening, but data on repeated screening outcomes are …

Background The use of prostate-specific antigen (PSA) testing to screen for prostate cancer
has been fraught with under-and overdiagnosis. Short, noncontrast magnetic resonance …